HABA Laboratories, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
635.00
-1,843.00
-548.00
-266.00
283.00
1,927.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
880.00
-688.00
37.00
1,062.00
36.00
-775.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,621.00
-587.00
55.00
1,714.00
534.00
675.00
Cash Flow from Investing Activities
-147.00
-441.00
-214.00
-216.00
-925.00
-920.00
Cash Flow from Financing Activities
-689.00
171.00
-676.00
-1,512.00
825.00
-448.00
Net Cash Inflow / Outflow
784.00
-858.00
-833.00
-12.00
435.00
-694.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
1.00
2.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of HABA Laboratories, Inc.
Figures in Million
consolidated Cash Flow Results
Change(JPY)
Change(%)
Profit Before Tax
635.745
1910.802
-1,275.00
-66.73%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
880.64
-812.991
1,692.00
208.32%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1621.011
1540.093
81.00
5.25%
Cash Flow from Investing Activities
-147.179
-2761.467
2,614.00
94.67%
Cash Flow from Financing Activities
-689.491
2232.074
-2,921.00
-130.89%
Net Cash Inflow / Outflow
784.341
1008.53
-224.00
-22.23%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-2.17
2.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 375.72% vs -1,150.68% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
1,621.01
-587.92
375.72%






